DME Capital Management, LP 13D and 13G filings for Coya Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:26 pm Purchase | 2024-12-31 | 13G | Coya Therapeutics, Inc. COYA | DME Capital Management, LP | 1,651,440 9.900% | 1,651,440 (New Position) | Filing |